Bank of Montreal
LEXX icon

Bank of Montreal’s Lexaria Bioscience LEXX Stock Holding History

Bank of Montreal’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.9K Sell
936
-3
-0.3% -$33 ﹤0.01% 3550
2025
Q4 		$8.69K Buy
939
+3
+0.3% +$43 ﹤0.01% 3434
2025
Q3 		$13.3K Hold
936
– – ﹤0.01% 3334
2025
Q2 		$12.2K Hold
936
– – ﹤0.01% 3346
2025
Q1 		$24K Buy
936
+3
+0.3% +$76 ﹤0.01% 3189
2024
Q4 		$29.4K Hold
933
– – ﹤0.01% 3202
2024
Q3 		$42.3K Buy
+933
New +$44.5K ﹤0.01% 3444
2021
Q2 		– Sell
-2
Closed – – 4365
2021
Q1 		$0 Buy
+2
New +$176 ﹤0.01% 5238

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Bank of Montreal's LEXX Position: Q1 2026 in Review

Bank of Montreal reduced its Lexaria Bioscience (LEXX) stake by 0.32% in Q1 2026, selling an estimated $33 and leaving 936 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3550.

Bank of Montreal first reported a position in LEXX in Q1 2021 and has held it in 8 quarters since. The position peaked at $42.3K in Q3 2024. 25 funds tracked by Wall St. Rank hold LEXX as of Q1 2026.

  • Bank of Montreal held 936 shares of Lexaria Bioscience worth $10.9K as of Q1 2026.
  • Bank of Montreal sold 3 Lexaria Bioscience shares in Q1 2026, an estimated $33.
  • Lexaria Bioscience made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #3550 holding.
  • Bank of Montreal first reported a position in Lexaria Bioscience in Q1 2021 and has held it in 8 quarters since.
  • Bank of Montreal's Lexaria Bioscience position peaked at $42.3K in Q3 2024.
  • 25 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.